Johan R. de Jong

3.9k total citations · 1 hit paper
55 papers, 3.1k citations indexed

About

Johan R. de Jong is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Johan R. de Jong has authored 55 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Radiology, Nuclear Medicine and Imaging, 17 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Johan R. de Jong's work include Medical Imaging Techniques and Applications (13 papers), Radiopharmaceutical Chemistry and Applications (11 papers) and HER2/EGFR in Cancer Research (8 papers). Johan R. de Jong is often cited by papers focused on Medical Imaging Techniques and Applications (13 papers), Radiopharmaceutical Chemistry and Applications (11 papers) and HER2/EGFR in Cancer Research (8 papers). Johan R. de Jong collaborates with scholars based in Netherlands, Switzerland and United States. Johan R. de Jong's co-authors include Elisabeth G.E. de Vries, Marjolijn N. Lub–de Hooge, Adrienne H. Brouwers, Eli Dijkers, Jos G. W. Kosterink, Thijs H. Oude Munnink, Guus AMS van Dongen, Carolina P. Schröder, P. L. Jager and Rudi Dierckx and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and NeuroImage.

In The Last Decade

Johan R. de Jong

53 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer

2010 634 citations Eli Dijkers, Thijs H. Oude Munnink et al. profile →

Peers

Countries citing papers authored by Johan R. de Jong

Since Specialization

Citations

This map shows the geographic impact of Johan R. de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan R. de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan R. de Jong more than expected).

Fields of papers citing papers by Johan R. de Jong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan R. de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan R. de Jong. The network helps show where Johan R. de Jong may publish in the future.

Co-authorship network of co-authors of Johan R. de Jong

This figure shows the co-authorship network connecting the top 25 collaborators of Johan R. de Jong. A scholar is included among the top collaborators of Johan R. de Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan R. de Jong. Johan R. de Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	RaCaT: An open source and easy to use radiomics calculator tool 2019 ·PLoS ONE ·Elisabeth Pfaehler, Alex Zwanenburg, Johan R. de Jong, Ronald Boellaard	64
2	89Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up 2018 ·European Journal of Nuclear Medicine and Molecular Imaging ·Frederike Bensch, Adrienne H. Brouwers, Marjolijn N. Lub–de Hooge, Johan R. de Jong, Bert van der Vegt, Stefan Sleijfer, Elisabeth G.E. de Vries, C.P. Schröder	104
3	SMART (SiMulAtion and ReconsTruction) PET: an efficient PET simulation-reconstruction tool 2018 ·EJNMMI Physics ·Elisabeth Pfaehler, Johan R. de Jong, Rudi Dierckx, Floris H. P. van Velden, Ronald Boellaard	16
4	89Zr-Lumretuzumab PET Imaging before and during HER3 Antibody Lumretuzumab Treatment in Patients with Solid Tumors 2017 ·Clinical Cancer Research ·Frederike Bensch, Laetitia E. Lamberts, (unknown), Annelies Jorritsma‐Smit, Marjolijn N. Lub–de Hooge, Anton G.T. Terwisscha van Scheltinga, Johan R. de Jong, Jourik A. Gietema, Carolien P. Schröder, Marlène Thomas, Wolfgang Jacob, K. Abiraj, Céline Adessi, Georgina Meneses‐Lorente, Ian James, Maja Weisser, Adrienne H. Brouwers, Elisabeth G.E. de Vries	57
5	In Vivo Evaluation of ¹¹C-Preladenant for PET Imaging of Adenosine A_2A Receptors in the Conscious Monkey 2017 ·Journal of Nuclear Medicine ·(unknown), Ronald Boellaard, Kiichi Ishiwata, Muneyuki Sakata, Rudi Dierckx, Johan R. de Jong, Shingo Nishiyama, Hiroyuki Ohba, Hideo Tsukada, Erik F. J. de Vries, Philip H. Elsinga	17
6	In vitro imaging of bacteria using 18F-fluorodeoxyglucose micro positron emission tomography 2017 ·Scientific Reports ·(unknown), Jürgen W. A. Sijbesma, Rocío Aguilar Suárez, Johan R. de Jong, Hendrikus H. Boersma, Gert Luurtsema, Philip H. Elsinga, Andor W.J.M. Glaudemans, Gooitzen M. van Dam, Jan Maarten van Dijl, Riemer H. J. A. Slart, Marleen van Oosten	21
7	Effects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study 2016 ·Journal of Nuclear Medicine ·Esther N. Klein Hesselink, Adrienne H. Brouwers, Johan R. de Jong, Anouk N.A. van der Horst-Schrivers, Robert P. Coppes, Joop D. Lefrandt, Piet L. Jager, Arjan Vissink, Thera P. Links	46
8	ImmunoPET with Anti-Mesothelin Antibody in Patients with Pancreatic and Ovarian Cancer before Anti-Mesothelin Antibody–Drug Conjugate Treatment 2015 ·Clinical Cancer Research ·Laetitia E. Lamberts, C. Willemien Menke‐van der Houven van Oordt, (unknown), Frederike Bensch, (unknown), Johannes Voortman, Otto S. Hoekstra, Simon P. Williams, Bernard M. Fine, Daniel Maslyar, Johan R. de Jong, Jourik A. Gietema, Carolien P. Schröder, Alphons H.H. Bongaerts, Marjolijn N. Lub–de Hooge, Henk M.W. Verheul, Sandra Sanabria Bohórquez, Andor W.J.M. Glaudemans, Elisabeth G.E. de Vries	77
9	¹¹¹In-Trastuzumab Scintigraphy in HER2-Positive Metastatic Breast Cancer Patients Remains Feasible during Trastuzumab Treatment 2014 ·Molecular Imaging ·Sietske B.M. Gaykema, Johan R. de Jong, Patrick J. Perik, Adrienne H. Brouwers, Carolien P. Schröder, Thijs H. Oude Munnink, Alphons H.H. Bongaerts, Elisabeth G.E. de Vries, Marjolijn N. Lub–de Hooge	39
10	Impact of PSF and ToF on the EANM procedure guideline for tumour PET imaging. 2013 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Johan R. de Jong, Rudi Dierckx, Antonius Willemsen	0
11	Serial Zr-89-bevacizumab PET Imaging in Metastatic Renal Cell Carcinoma Patients treated with Sunitinib, or Bevacizumab Plus Interferon. 2012 ·Data Archiving and Networked Services (DANS) ·Sjoukje F. Oosting, (unknown), Thijs H. Oude Munnink, Marjolijn N. Lub–de Hooge, Harry Hollema, Johan R. de Jong, Sanne de Haas, (unknown), Willem Sluiter, Alphons H.H. Bongaerts, Jourik A. Gietema, Rudi Dierckx, Elisabeth G.E. de Vries, Adrienne H. Brouwers, Igle J. de Jong	0
12	Characteristics of a new system for monitoring the leakage factor during regional hyperthermic isolated limb perfusion 2011 ·Nuclear Medicine Communications ·Roel Wierts, Johan R. de Jong, Sergiy V. Lazarenko, Anne M. J. Paans, Rudi Dierckx, (unknown)	2
13	Quantitative multi-pinhole small-animal SPECT: uniform versus non-uniform Chang attenuation correction 2011 ·Physics in Medicine and Biology ·(unknown), Johan R. de Jong, (unknown), Frans van der Have, Brendan Vastenhouw, Peter Laverman, Otto C. Boerman, R. A. Dierckx, Freek J. Beekman	26
14	Reduction of artefacts caused by hip implants in CT-based attenuation-corrected PET images using 2-D interpolation of a virtual sinogram on an irregular grid 2011 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Johan R. de Jong, Jan Pruim, Rudi Dierckx, Habib Zaidi	23
15	VEGF-PET Imaging Is a Noninvasive Biomarker Showing Differential Changes in the Tumor during Sunitinib Treatment 2010 ·Cancer Research ·Wouter B. Nagengast, Marjolijn N. Lub–de Hooge, Sjoukje F. Oosting, Wilfred F.A. den Dunnen, (unknown), Adrienne H. Brouwers, Johan R. de Jong, Patricia M. Price, Harry Hollema, Geke A.P. Hospers, Philip H. Elsinga, Jan Willem Hesselink, Jourik A. Gietema, Elisabeth G.E. de Vries	83
16	VEGF-SPECT with In-111-bevacizumab in stage III/IV melanoma patients 2010 ·European Journal of Nuclear Medicine and Molecular Imaging ·Marjolijn N. Lub–de Hooge, (unknown), Adrienne H. Brouwers, Johan R. de Jong, Harry Hollema, Rudi Dierckx, Nanno H. Mulder, Elisabeth G.E. de Vries, H.J. Hoekstra, Geke A.P. Hospers	1
17	Radiation dosimetry of 111In-bevacizumab used for VEGF-SPECT in melanoma patients 2010 ·European Journal of Nuclear Medicine and Molecular Imaging ·Johan R. de Jong, (unknown), (unknown), Rudi Dierckx, Geke A.P. Hospers, Adrienne H. Brouwers, Elisabeth G.E. de Vries, (unknown)	1
18	Development and Characterization of Clinical-Grade ⁸⁹Zr-Trastuzumab for HER2/neu ImmunoPET Imaging 2009 ·Journal of Nuclear Medicine ·Eli Dijkers, Jos G. W. Kosterink, (unknown), Lars R. Perk, Guus A.M.S. van Dongen, Joost Bart, Johan R. de Jong, Elisabeth G.E. de Vries, Marjolijn N. Lub–de Hooge	271
19	Steroid hormones affect binding of the sigma ligand 11C-SA4503 in tumour cells and tumour-bearing rats 2009 ·European Journal of Nuclear Medicine and Molecular Imaging ·Anna A. Rybczynska, Philip H. Elsinga, Jürgen W. A. Sijbesma, Kiichi Ishiwata, Johan R. de Jong, Erik F. J. de Vries, Rudi Dierckx, Aren van Waarde	24
20	A comparison of micro-CT, microradiography and histomorphometry in bone research 2008 ·Archives of Oral Biology ·(unknown), Jurjen Schortinghuis, Johan R. de Jong, M.C.D.N.J.M. Huysmans, M. B. M. van Leeuwen, Gerry M. Raghoebar, R. Bös, Boudewijn Stegenga	57

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact